Bioshares latest addition included an update on Opthea.
Here are a few edited highlights. Opthea is building a compelling case for its ophthalmology drug candidate,OPT-302. Having delivered positive results in the first indication of wet AMD in a PhaseIb/IIa trial last year, it has now produced early positive data from its Phase Ib/IIa study indiabetic macular edema. It is also strengthening the scientific rationale that underpinsits technology, which will support a future commercial transaction of OPT-302.
In relation to the DME trial. In the five patients with bilateral disease, Opthea plus Eylea achieved a mean 10 lettergain in vision compared to only a 2.6 letter improvement in patients receivingEylea in the second eye. The combinationtreatment achieved a central subfield thickness reduction of 80uM compared to just a 6uM reduction in theEylea only treatment alone.
It was also explained why the mechanism of action of OPT-302 may have efficacy in DME
The company expects to receive a $12 million tax rebate forlast financial year.
Although data for its two trials is between 12 - 18 months away,investors with patience may be very well rewarded with this stock.The company's core asset OPT-302 has the potential to deliversubstantial value to the company if positive trial data continues to flow.
- Forums
- ASX - By Stock
- Ann: Opthea Reports Positive Data from Ph1b DME Study of OPT-302
Bioshares latest addition included an update on Opthea. Here are...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $467.8M |
Open | High | Low | Value | Volume |
38.0¢ | 39.0¢ | 37.5¢ | $176.6K | 463.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 121324 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 90033 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 121324 | 0.380 |
8 | 206689 | 0.375 |
15 | 336846 | 0.370 |
4 | 11693 | 0.365 |
7 | 278244 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 90033 | 3 |
0.395 | 28147 | 2 |
0.400 | 140733 | 2 |
0.405 | 30000 | 1 |
0.410 | 98513 | 3 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |